Related Experiment Videos
[IgA nephropathy: frequent, but rarely diagnosed]
1Abteilung für Nephrologie und Klinische Immunologie, Universitätsklinikum der RWTH Aachen, Aachen, Germany. juergen.floege@rwth-aachen.de
Der Internist
|October 21, 2003
Summary
IgA nephropathy (IgAN) is a common kidney disease. Early detection of IgAN risk factors like proteinuria and hypertension is crucial for slowing disease progression and preventing kidney failure.
Area of Science:
- Nephrology
- Immunology
Context:
- IgA nephropathy (IgAN) is the most prevalent form of glomerulonephritis globally.
- It often presents in adolescents and young adults with hematuria, proteinuria, hypertension, or renal insufficiency.
- Many cases are asymptomatic and discovered incidentally during autopsies, indicating significant underdiagnosis.
Purpose:
- To highlight the clinical manifestations and diagnostic challenges of IgA nephropathy.
- To identify key predictors of progressive renal failure in IgAN patients.
- To emphasize the importance of early diagnosis and intervention for managing IgAN and its complications.
Summary:
- IgAN commonly affects younger individuals, presenting with varied urinary and renal symptoms.
- Approximately 20-30% of diagnosed patients develop chronic kidney disease.
- Risk factors for progression include proteinuria, hypertension, and existing renal impairment at diagnosis.
Impact:
- Early identification of high-risk IgAN patients can significantly slow or halt kidney function decline.
- Understanding IgAN progression is vital for therapeutic strategies and patient management.
- Renal transplant recurrence of IgAN affects about 25% of patients, impacting graft survival.